A diverse group of research and scientific organizations, as well as those directly involved in commercializing new products, launched Bayh-Dole 40, a coalition that will celebrate and protect the University and Small Business Patent Procedures Act o...
The creators of the app, Dr. Rebecca Dillingham and Karen Ingersoll, who holds a doctorate in psychiatry, are the recipients of this year’s Edlich-Henderson Innovator of the Year award. Bestowed by the UVA Licensing & Ventures Group, the endowed ...
Mugler was previously recognized, with his colleague James R. Brookeman, as the 2009 Edlich-Henderson Inventors of the Year by the UVA Patent Foundation, now known as the UVA Licensing & Ventures Group....
UVA’s Licensing & Ventures Group has honored our Rebecca Dillingham, MD, and Karen Ingersoll, PhD, as the 2020 Edlich-Henderson Innovators of the Year for creating an app to help people living with HIV....
University of Virginia President Jim Ryan presented the 2019 Research Achievement Awards to 13 UVA faculty members at the dinner event....
Ceres Nanosciences, Inc. (Ceres) today announced it has been awarded a $225,000 Phase I SBIR grant from the NIH to apply the Nanotrap® technology for improved quality testing and for the decontamination of animal serum used in cell and tissue culture...
2020 Innovators of the Year Improve Care Retention and Outcomes Among HIV Patients with Innovative Mobile Health Technology UVA Licensing & Ventures Group honors interdisciplinary UVA School of Medicine research team Charlottesville, VA (Janu...
The recently USFDA approved artificial pancreas system is now commercially available in the United States! The life-changing technology developed at UVA and championed by UVA startup TypeZero Technologies (acquired by Dexcom in 2018) integrates with ...
The U.S. Food and Drug Administration has approved an artificial pancreas system – based on technology from the University of Virginia Center for Diabetes Technology – that automatically monitors and regulates blood glucose levels for Type 1 diabetes...
We are thrilled to share with you our 2019 annual report, Impact. As we close the chapter on the University's latest strategic plan, our report is a look back at LVG's progress during the last five years. We look forward to your continued support in ...